Article By:
KKD Healthcare Analytics
Monday, June 12, 2017 9:17 AM EDT
Johnson & Johnson announced receiving the approval from the regulatory authorities in the EU for its planned $30 billion takeover of Actelion. Teva announced the commercial launch of the generic version of Novartis’ Pataday.